U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07729930) titled 'Dietary Supplements and Middle Aged Women (Creatine)' on July 08. Brief Summary: This stud... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731828) titled 'Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemot... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730827) titled 'Community-Informed Interventions for Equitable Congestive Heart Failure Management in Prima... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07732309) titled 'A Study of ATG-201 in Adult Participants With Autoimmune Diseases' on July 24. Brief Summa... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More